3 Undervalued Pharmaceuticals Stocks for Friday, July 24
Discover the top 3 undervalued Pharmaceuticals stocks for Friday, July 24 based on AAII’s Stock Grades.Jenna Brashear
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
Trulieve Cannabis Corp. operates as a cannabis retailer in the United States. The company cultivates, processes, and manufactures cannabis products and distributes its products to its dispensaries, as well as through home delivery. It sells flowers, edibles, vapes, oral, topical, concentrates, and accessories under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, and Roll One brands. The company operates dispensaries in Florida, Arizona, Georgia, Ohio, Maryland, West Virginia, Connecticut, and Pennsylvania. It operates cultivation and processing facilities in Arizona, Colorado, Florida, Georgia, Maryland, Pennsylvania, and West Virginia. The company also offers medical cannabis dispensary in North Miami Beach, Florida. Trulieve Cannabis Corp. was formerly known as Schyan Exploration Inc./Exploration Schyan Inc. and changed its name to Trulieve Cannabis Corp. in September 2018. Trulieve Cannabis Corp. was incorporated in 1940 and is headquartered in Tallahassee, Florida.
Commentary & Analysis
Why Trulieve Cannabis Corp.’s (TRLV) Stock Is Down 6.39%
As of Wednesday, June 24, Trulieve Cannabis Corp.’s TRLV share price has dipped by 6.39%, which has investors questioning if this is right time to buy.Jenna Brashear
Why Trulieve Cannabis Corp.’s (TRLV) Stock Is Down 6.58%
As of Tuesday, June 23, Trulieve Cannabis Corp.’s TRLV share price has dipped by 6.58%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Why Trulieve Cannabis Corp.’s (TRLV) Stock Is Down 6.34%
As of Monday, June 22, Trulieve Cannabis Corp.’s TRLV share price has dipped by 6.34%, which has investors questioning if this is right time to buy.Rosalio Madrigal
3 Undervalued Pharmaceuticals Stocks for Thursday, June 18
Discover the top 3 undervalued Pharmaceuticals stocks for Thursday, June 18 based on AAII’s Stock Grades.Michael Rose
Financial Summary
| Share Statistics | TRLV | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $1,663.5 | $579.1 | 51% |
|
| Shares Out (Mil) | 192.5 | 43.0 | 75% |
|
| Institutional Ownership | 63.2% | 84.3% | 40% |
|
| Float (Mil) | 167.6 | 46.8 | 71% |
|
| Beta | 1.83 | 0.62 | 89% |
|
| Avg Daily Volume (000s) | 769 | 285 | 66% |
|
| Price Change (52-week) |
85.8% | 63.8% | 89% |
|
| Growth | TRLV | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 17.8% | 6.7% | 78% |
|
| Net Income (5yr) | (30.9%) | (1.4%) | 13% |
|
| EPS (5yr) | (25.8%) | 14.9% | 10 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (30.1%) | (14.9%) | 19% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 1 | na | na | |
| Current EPS | $0.030 | na | na | |
| Month Ago EPS | $0.030 | na | na | |
| # Rev Up | 0 | na | na | |
| # Rev Down | 1 | na | na | |
| Three Months Ago EPS | ($0.050) | na | na | |
| Year/Year Chg | 66.7% | na | (174.3%) | |
| Financials | TRLV | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $1,170 | $272 | 53% |
|
| Net Income (TTM) (Mil) | ($81) | ($11) | 12% |
|
| EPS (TTM) | ($0.423) | ($0.500) | 29% |
|
| Operating Cash Flow (TTM) (Mil) | $277 | ($6) | 64% |
|
| Net Cash Flow (TTM) (Mil) | $24 | $4 | 64% |
|
| Long-Term Debt (Q1) (Mil) | $599 | $7 | 61% |
|
| Enterprise Value (Q1) (Mil) | $1,858 | $522 | 48% |
|
| Valuation | TRLV | Industry Median |
Percentile (All Stocks) |
|
| P/B | 1.43 | 2.73 | 38% |
|
| P/E | na | 20.5 | na |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | na | 1.2 | na |
|
| Ratios | TRLV | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 59.7% | 65.9% | 72% |
|
| Net Margin | (6.9%) | 0.7% | 23% |
|
| ROA | (2.9%) | (24.6%) | 33% |
|
| ROE | (6.8%) | (19.7%) | 30% |
|
| Liabilities to Assets | 58.7% | 35.5% | 52% |
|
| F-Score | 5 | 3 | 51% |
|
Trulieve Cannabis Corp. did not pass any screens on 7/31/2026.
